Correlation Between Janux Therapeutics and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Janux Therapeutics and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Janux Therapeutics and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Janux Therapeutics and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Janux Therapeutics and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Janux Therapeutics with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Janux Therapeutics and Acrivon Therapeutics,.
Diversification Opportunities for Janux Therapeutics and Acrivon Therapeutics,
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Janux and Acrivon is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Janux Therapeutics and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Janux Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Janux Therapeutics are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Janux Therapeutics i.e., Janux Therapeutics and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Janux Therapeutics and Acrivon Therapeutics,
Given the investment horizon of 90 days Janux Therapeutics is expected to under-perform the Acrivon Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Janux Therapeutics is 1.49 times less risky than Acrivon Therapeutics,. The stock trades about -0.37 of its potential returns per unit of risk. The Acrivon Therapeutics, Common is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest 669.00 in Acrivon Therapeutics, Common on October 20, 2024 and sell it today you would lose (91.00) from holding Acrivon Therapeutics, Common or give up 13.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Janux Therapeutics vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Janux Therapeutics |
| Acrivon Therapeutics, |
Janux Therapeutics and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Janux Therapeutics and Acrivon Therapeutics,
The main advantage of trading using opposite Janux Therapeutics and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Janux Therapeutics position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Janux Therapeutics vs. Mineralys Therapeutics, Common | Janux Therapeutics vs. Anebulo Pharmaceuticals | Janux Therapeutics vs. Rezolute | Janux Therapeutics vs. Keros Therapeutics |
| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Correlations Find global opportunities by holding instruments from different markets |